Published on : Nov 10, 2015
Invibio has completed their biocompatibility testing in the China market, making way for the China Drug Administration and China Food approval and the local legal compliance for Invibio’s PEEK-Optima HA Enhanced spinal fusion implants. With the new and enhanced spinal fusion implant devices, the China medical devices industry is expected to reach new heights in the coming few years.
John Devine, the medical business director, said that Invibio is totally committed and interested in building their activities in various regions across China. With this, the company is planning to expand their portfolio of enhanced spinal fusion implant devices throughout the fast expanding medical devices market, where there is increasing demand for innovative medical solutions. Invibio is determined to work with leading and emerging manufacturers and companies in the medical devices market in a cost-effective manner, stated John. Reliable and proven surgical solutions will be provided to the manufacturers, added John.
Here are the Five Key Highlights: